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1.  IntroductIon
Cholera is a potentially epidemic and life-threatening 
diarrheal disease that continues to strike many developing 
countries, where access to safe drinking water and adequate 
sanitation cannot be assured1. Almost every developing 
country is now facing either a cholera outbreak or the 
threat of epidemic, which along with serious public health 
problems severely affects the economy too. The World Health 
Organisation (WHO) estimates every year there are 1.4 to 4.3 
million cases of cholera associated with 28,000 to 1,42,000 
deaths worldwide2. The disease is endemic in many states of 
India as per the new definition of endemic cholera devised by 
WHO Strategic Advisory Group of Experts (SAGE) in 20093.
The introduction of oral rehydration suspension (ORS) 
for cholera treatment by the WHO greatly diminished the 
disease mortality. Use of effective antibiotics shortens the 
duration of diarrhea, reduction in the disease severity thereby 
curbing secondary transmission. While considering cholera 
management, the emergence of wide-spread antibiotic 
resistant V. cholerae strains presents the greatest challenges for 
the developing countries4. Occurrence of multiple antibiotic 
resistant V. cholerae has been on the rise among outbreak 
strains5,6. Switch in the resistance pattern from one drug to 
another has also been observed during the management of the 
outbreaks7. Now, most of the V. cholerae isolates are becoming 
resistant to low cost first-line drugs like tetracycline and 
trimethoprim-sulfamethoxazole8. Multidrug resistance in V. 
cholerae is a result of acquisition of genetic elements located 
within the chromosomal DNA, such as integrons and SXT 
constin, as vehicles of the transport of genetic determinants 
responsible for resistance9-11. Recently, most of the large 
cholera outbreaks were associated with V. cholerae having 
multidrug resistance mediated by SXT and integron elements12-
14. Thus, antimicrobial resistance can increase the outbreak 
size, duration and case fatality rates. Therefore, alternative 
treatment approaches like use of antibacterial herbs need to be 
explored for combating the disease.
The importance of garlic (Allium sativum) was recognised 
for many centuries in early Chinese, Egyptian and Indian 
civilisations as a herbal or traditional medicine. It is a member 
of the Liliaceae family and probably one of the earliest 
known medicinal plants used worldwide to reduce various 
risk factors15. It has sulfur containing compounds like allicin 
which is considered responsible for its antibacterial properties. 
Allicin is biosynthesised from alliin by the action of enzyme 
alliinase. It harbors a thiosulfinate functional group, R-S(O)-
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In recent years, emerging trend of antibiotic resistance in Vibrio cholerae associated with cholera epidemics is 
a matter of serious concern for the management of the disease. Indiscriminate use of antibiotics generally results in 
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was performed against all the multidrug resistant strains of V. cholerae. The garlic extracts showed antibacterial 
activity against all the V. cholerae strains tested, irrespective of their origin, multidrug resistance and virulence. 
Antibacterial efficacy of garlic on V. cholerae was also evident from in vivo study on sealed adult mice model. 
Thus, the Garlic extract harnesses the potential to control infection of multidrug resistant V. cholerae, especially in 
outbreak like situations in remote and under developed areas where drug supply itself is a challenge.
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S-R which is associated with main antimicrobial effect due to 
its chemical reaction with thiol groups of various microbial 
enzymes essential for metabolism16.
Antibacterial properties of garlic extract or allicin have 
been reported against a number of pathogenic bacteria viz. E. 
coli17, V. cholerae18, 19, Pseudomonas aeruginoa20, Salmonella 
typhimurium18, Streptococcus pneumoniae21, Staphylococcus 
aureus22 and Methicillin resistant S. aureus (MRSA)23,24. 
Present study was aimed to check the efficacy of garlic extract 
against multidrug resistant V. cholerae having epidemic 
potential isolated from different outbreaks in India. 
2.  MAtErIAl And MEthodS 
2.1 V. cholerae Strains
Total 55 clinical isolates collected from different parts of 
India (Table 1) were used in this study. 
2.2 Antimicrobial Susceptibility Testing
Clinical strains of V. cholerae were tested for antimicrobial 
drug susceptibility by disc diffusion method on Mueller–
Hinton agar (MHA) according to the standard procedure25. 
The antibiotic discs (Oxoid limited, UK and Himedia, 
India) used were: ampicillin (Amp), chloramphenicol (chl), 
ciprofloxacin (Cip), doxycycline (Dox), erythromycin (Ery), 
gentamicin (Gen), nalidixic acid (NA), streptomycin (Str), 
sulfamethoxazole (Sul), tetracycline (TE), trimethoprim (Tri) 
and the vibrio static agent O/129. 
2.3 Preparation of Garlic Extract 
Garlic (Allium Sativum) extraction was done according 
to the earlier described methods21. The extract was stored in 
sterilised bottles at - 20 °C. One ml of aqueous extract contained 
material from 500 mg of garlic. The required dilutions of the 
garlic extract were prepared in autoclaved double distilled 
water on the day of experiment. The extract was centrifuged at 
5000 g for 15 min; the supernatant was collected and filtered 
through 0.45 µm membrane filters.
2.4 Determination of Minimum Inhibitory 
Concentration 
MICs of garlic against the randomly selected clinical 
and environmental V. cholerae strains was determined by agar 
well diffusion and broth micro-dilution using two-fold serial 
dilutions, as per standard procedure25. 
2.5 Time Kill Assay
Randomly selected V. cholerae clinical and environmental 
strains carrying SXT and integron were subjected to time kill 
assay23. The strains were overnight grown in Mueller Hinton 
broth (MHb). bacterial inocula equal to 5 x 105 CfU/ml were 
added to a double strength of MHb (5 ml) containing garlic 
extract (equivalent to 1 x MIC or 10 x MIC of that particular 
bacterial strain) and the volume was adjusted to 10 ml by 
adding sterile double distilled water. The control group which 
did not receive garlic was run in parallel. A 100 µl of culture 
broth was harvested at 0 h, 2 h, 4 h, 6 h, and 8 h followed by 
10-fold serial dilutions of the inoculums in normal saline and 
plating on MHA plates. After incubation at 37 °C for 24 h, the 
colonies were counted. Growth was observed further for 48 h.
2.6 Analysis of Antimicrobial Activity on Thin 
Layer Chromatographic (TLC) Plate
Garlic extract was run on TLC plates using solvent 
containing ethyl acetate, methanol and water (81:11:8). V. 
cholerae strains grown to exponential phase were harvested, 
the inoculum was adjusted to 0.5 Mcfarland standard and 
Year of 
isolation Location 
No. of 
strains 
Efficacy 
of garlic
Antibiotic phenotype 
Antibiotic genotype 
reference
SXt Integron 
2004 Chennai, India 05 + Na,  Str, Sul, Tri, O129 + + 11
2007 Rayagada, Orissa 05 + Na, Str, Sul, Tri, O129 + + 6, 8
2007 Kalahandi, Orissa 05 + Na, Str, Sul, Tri, O129 + + 6, 8
2007 Koraput, Orissa 05 + Na, Str, Sul, Tri, O129 + + 6, 8
2009 Datia,  Morena 05 + Na, Str, Sul, Tri, O129 + + 
2009 Hydrabad 05 + Na, Str, Sul, Tri, O129 + + 12
2010 Solapur, Maharastra 05 + Na, Str, Sul, Tri, O129 + + 
2010 Orissa 05 + Na, Str, Sul, Tet,  Tri, O129 + + 4
2011 Solapur 05 + Na, Str, Sul, Tet,  Tri, O129 + + 
2011 Gwalior 05 + Na, Str, Sul, Tri, O129 + + 
2012 Yavatmal 05 + Na, Str, Sul,  Tri, O129 + + 5,  10
Total 55
Table 1.  Susceptibility of Multidrug resistant V. cholerae clinical isolates (collected from different outbreaks in India) towards 
aqueous extract of garlic
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further diluted in molten Mueller Hinton Agar (45 °C - 50 °C) 
at a final concentration of 5 x 105 CfU/ml. The suspension was 
immediately overlaid on prepared TLC plate and incubated at 
37 °C for 24 h. 
2.7 LC-MS Analysis of Garlic Extract
for liquid chromatography, the following solvent 
composition was made for sample introduction: solvent A 
(0.01M ammonium formate in water) and solvent b (0.01M 
ammonium formate in methanol). Chromatographic separations 
were performed using 0 per cent b (0 – 3 min), 0 – 100 per cent 
B (3 – 30 min) and 100 per cent B (30 – 40 min) at a flow 
rate of 200 µLmin-1. Column temperature was kept at 25 °C. 
Samples were injected through a Rheodyne injector (Model 
7010) fitted with 2 µL loop.
Mass spectral analyses were performed on Micromass 
Q-Tof high resolution mass spectrometer equipped with 
electrospray ionisation (ESI) on Masslynx 4.0 data acquisition 
system. ESI was used in +ve ionisation mode. Capillary and 
tube lens voltages were optimised to give the maximum 
response. Helium was continually flowing into the collision 
cell at a pressure of 0.1 Pa. (10−3 Torr) during the electrospray 
ionisation tandem-mass spectrometry (ESI-MS) operation. The 
ESI-MS data were acquired over the mass range of m/z 100 
amu – 400 amu. The mass spectra were obtained at collision 
energy of 35 per cent.
2.8  In vivo Testing of Garlic Extract in Cholera 
Model
balb/c mice (weight 20 g - 24 g) were used in this study. 
Sealed adult mice (SAM) model was prepared according to 
the previously described methods with some modifications26. 
In brief, mice were starved overnight, anorectally canal was 
sealed with nail polish, given 500 µl of 2 per cent NaHCO3 
prior to administration of either bacterial inocula (109 CfU/
ml) or bacteria followed by herbal extract (n = 4 mice/group) 
after 1 h and sacrificed at 6 h or 24 h. The intestine weight 
to carcass weight ratios was determined. In this experiment, 
we used Haitian type of CT producing strains as the strains 
were associated with a higher mortality in the epidemics. The 
control group of SAM (n = 4) received only PbS. They were 
kept in wired-mesh polyacrylic cages and fed with the standard 
rodent pellet diet and given water ad libitum. The animals were 
housed under standard laboratory environmental conditions for 
acclimatisation prior to making cholera model and performing 
the experiments.
3  rESultS
3.1 Antimicrobial Susceptibility Pattern
The clinical V. cholerae isolates exhibited varied 
phenotypic resistance towards the antibiotics ampicillin, 
chloramphenicol, aminoglycosides, macrolides, quinolones, 
fluoroquinolones, sulfomethoxazole, trimethoprim and 
tetracyclines. The antibiogram of clinical isolates has been 
presented in Table 1.
3.2 Antibacterial Activity of Garlic Against V. 
cholerae Strains
Garlic aqueous extract presented antibacterial activity 
against all the clinical isolates tested (Table 1). The garlic 
extract (500 mg/ml) exhibited the zone of inhibition in the 
range of 19 mm to 27 mm diameter against clinical isolates 
(fig. 1). The MIC in broth dilution ranged from 4 mg/ml - 
16 mg/ml of garlic extract for V. cholerae ATCC 14033 and 
randomly selected epidemic strains resistant to important drugs 
used for cholera treatment viz. tetracycline and ciprofloxacin. 
3.3 Time Kill Curve
Time kill curves showed that 1X MIC of garlic killed the 
strains within 6 h, whereas, 10X MIC of garlic greatly reduced 
the viable count and killed the strains within 4 h (fig. 2).
Figure 1.  Size of zones of inhibition with garlic aqueous 
extract (500 mg/mL) against multidrug resistant 
V. cholerae.
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Figure 2.  In vitro time dependent bactericidal of effect of garlic 
extract on multidrug resistant V. cholerae.  Minimum 
inhibitory concentration (MIC) of garlic extract was 
used as MIC-1X and MIC-10X (10 fold) in broth 
culture.
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3.4 Antimicrobial Activity of Garlic Extract on 
tlc Plate
The zone of clearance was observed on TLC plate 
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indicating the V. cholerae growth inhibition due to presence 
of active antimicrobial compound at that particular position. A 
0.54 Rf value was observed reflecting the zone of inhibition.
3.5 Allicin Peak Identified in LC-MS
Separation of the components of aqueous extracts of 
garlic was done on a C-18 column. In comparison to a reported 
retention time, the allicin peak has been tentatively identified 
(fig. 3) which is the main component of garlic. On heating the 
aqueous extract of garlic for about 10 min at boiling water, the 
allicin peak was reduced significantly as a result of thermal 
instability of allicin. To confirm the identity of the isolated 
allicin, the extracts were then analysed by LC-MS.
antibiotic-resistant strains of V. cholerae is being reported 
with increasing frequency. In the process, the bacteria are 
continuously changing their genetic makeup for sustained 
infectivity8,13,14,27. Acquisition of antibiotic resistance genes 
across genera and species is mediated through horizontal and 
lateral gene transfer of mobile genetic elements like SXT and 
integron10,28.
Inappropriate and inadequate practices like misuse, abuse 
and over prescription of antibiotics are common in developing 
countries29,30. In developing countries, the antimicrobial therapy 
is usually started even before the microbiological analysis5. 
Doxycycline and tetracycline are the preferred antibiotics given 
in severe cases for treatment but in recent year reemergence of 
tetracycline resistant clones have 
been documented in India and 
other parts of the world, raising 
the question for their use31. Till 
date V. cholerae has acquired 
resistance to all commonly 
available antibiotics, therefore 
in outbreak like situation the 
prescription of effective antibiotic 
for combating the disease based 
on the trend of resistance cannot 
be assured without knowing 
antibiogram in laboratory 
conditions, a process that takes at 
least 2 - 3 days. In that, situation 
garlic extract can be made easily 
available for severely diseased 
persons. Medicinal plants are 
a rich source of antimicrobial 
agents and provide a safer and 
cost effective way of treating 
bacterial infections. In Ayurvedic and Yunani medicine, herbs 
have been used to treat many infectious diseases for centuries 
including the treatment of dysentery and watery diarrhea. 
Garlic is commonly available and used as dietary supplement 
all over the world. It is also used to cure abdominal pain and 
severe diarrhea by Arabian herbalists32. The in vitro activity 
of garlic has been reported against diverse enteric pathogen 
and diarrheagenic bacteria like E. coli O157, Enterobacter 
cloacae, Enterococcus faecalis, citrobacter freundii, S. typhi, 
S. dysenteriae, and  V. cholerae17,18,20-22. 
The effect of garlic was bactericidal as there was 
no growth observed on bHI agar till 48 h following 8 h of 
treatment with garlic (8 mg/ml). The main antimicrobial effect 
of garlic is due to the presence of diallyl sulphides and allicin 
is the most abundant sulfoxide molecule in garlic extract 
responsible for therapeutic potential including bactericidal 
activity23,26. The functional group of allicin react with thiol 
groups in the active site of various microbial enzymes, e.g. 
alcohol dehydrogenase, thioredoxin reductase, and RNA 
polymerase and affect essential microbial metabolism16. Allicin 
is produced upon tissue damage from the non-proteinogenic 
amino acid alliin (S-allylcysteine sulfoxide) in a reaction that 
is catalysed by the enzyme alliinase16. The activity of alliinase 
reduces on boiling. Therefore, fresh garlic extracts is prepared 
Figure 3.  LC-MS profile of Allium sativum (garlic) extract.
Figure 4. In-vivo efficacy of garlic in cholera (SAM) model. 
A: Mice received buffer only, B: mice received V. 
cholerae and C: Mice received V. cholerae followed 
by administration of garlic extract.
3.6 In-vivo Efficacy of Herbs in Cholera Model
A doze of 1 x 109 CfU of the epidemic V. cholerae strains 
(carrying Haitian CT) was able to induce cholera as significant 
fluid accumulation was observed in SAM (Fig. 4). The group 
of SAM administered with garlic extract following 1x109 
CFU of the bacteria showed significant reduction in the fluid 
accumulation. The fA ratio of treated group was found very 
near to the control group which received only PbS.
4.  dIScuSSIon
Multiple antibiotic resistances among V. cholerae have 
emerged as a major problem worldwide. The occurrence of 
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for extraction of optimum active fractions. The European 
Scientific Cooperative on Phytotherapy recommended garlic 
to cure upper respiratory tract infections33. The antibacterial 
activity of garlic extract against intestinal bacteria is reported 
superior than tetracycline34. A human trial conducted in different 
hospitals in China revealed the efficacy of garlic preparation in 
controlling cryptosporidium parvum diarrhea in AIDS patients 
with weakened immune system35. Our study indicated that 
aqueous garlic juice can act as broad spectrum antibacterial 
agent in managing cholera outbreaks. furthermore, it can be 
used as nutritional supplement in the affected areas for the 
prevention of cholera spread. 
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